De Chang

4.9k total citations · 1 hit paper
62 papers, 1.4k citations indexed

About

De Chang is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, De Chang has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Infectious Diseases and 14 papers in Physiology. Recurrent topics in De Chang's work include Spaceflight effects on biology (13 papers), COVID-19 Clinical Research Studies (13 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). De Chang is often cited by papers focused on Spaceflight effects on biology (13 papers), COVID-19 Clinical Research Studies (13 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). De Chang collaborates with scholars based in China, United States and Taiwan. De Chang's co-authors include Lokesh Sharma, Charles S. Dela Cruz, Minggui Lin, Lai Wei, Guangfa Zhu, Lixin Xie, Hong‐Zhen Du, Yupei Zhao, Lei You and Yinghua Guo and has published in prestigious journals such as JAMA, Biochemical and Biophysical Research Communications and Journal of Bacteriology.

In The Last Decade

De Chang

59 papers receiving 1.4k citations

Hit Papers

Epidemiologic and Clinical Characteristics of Novel Coron... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
De Chang China 16 536 374 217 171 163 62 1.4k
Tieshan Teng China 12 426 0.8× 392 1.0× 82 0.4× 79 0.5× 137 0.8× 34 1.3k
Abualgasim Elgaili Abdalla Saudi Arabia 18 964 1.8× 392 1.0× 272 1.3× 184 1.1× 67 0.4× 52 1.9k
Chao Wu China 30 1.0k 1.9× 516 1.4× 190 0.9× 317 1.9× 227 1.4× 189 3.1k
Tongyu Zhu China 20 957 1.8× 699 1.9× 312 1.4× 241 1.4× 186 1.1× 52 2.3k
Xiaopeng Zhang China 22 549 1.0× 496 1.3× 212 1.0× 102 0.6× 58 0.4× 62 1.7k
Guillaume Butler‐Laporte Canada 18 748 1.4× 365 1.0× 88 0.4× 67 0.4× 106 0.7× 53 1.6k
Baoli Zhu China 15 621 1.2× 180 0.5× 194 0.9× 83 0.5× 201 1.2× 45 1.2k
Zhitao Yang China 21 313 0.6× 295 0.8× 85 0.4× 115 0.7× 150 0.9× 83 1.2k
Qingqing Wang China 12 525 1.0× 308 0.8× 156 0.7× 156 0.9× 93 0.6× 46 1.5k

Countries citing papers authored by De Chang

Since Specialization
Citations

This map shows the geographic impact of De Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Chang more than expected).

Fields of papers citing papers by De Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Chang. The network helps show where De Chang may publish in the future.

Co-authorship network of co-authors of De Chang

This figure shows the co-authorship network connecting the top 25 collaborators of De Chang. A scholar is included among the top collaborators of De Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De Chang. De Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chun, Li Zhang, Linyu Zhu, et al.. (2025). Benefits and challenges of host depletion methods in profiling the upper and lower respiratory microbiome. npj Biofilms and Microbiomes. 11(1). 130–130. 1 indexed citations
2.
Guo, Xin, Hong Zhang, Dandan Li, et al.. (2024). Early antiviral use and supplemental oxygen decrease the risk of secondary bacterial infections: a multi-centre, nested, case–control study. Journal of Hospital Infection. 156. 87–95.
3.
Chang, De, Ning Song, Jing Gao, et al.. (2023). The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China. Virology Journal. 20(1). 189–189. 6 indexed citations
4.
Jiang, Yunpeng, Hong‐Zhen Du, De Chang, et al.. (2023). High-throughput functional screen identifies YWHAZ as a key regulator of pancreatic cancer metastasis. Cell Death and Disease. 14(7). 431–431. 4 indexed citations
5.
Zhu, Ying, Lokesh Sharma, & De Chang. (2023). Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review. Frontiers in Immunology. 14. 1116131–1116131. 18 indexed citations
6.
Chang, De, et al.. (2023). Interactions between the lung microbiome and host immunity in chronic obstructive pulmonary disease. Chronic Diseases and Translational Medicine. 9(2). 104–121. 11 indexed citations
7.
Chang, De, et al.. (2021). Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. Frontiers in Microbiology. 12. 750662–750662. 160 indexed citations
8.
Xie, Chunmei, Qing Li, Linhai Li, et al.. (2021). Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19. Journal of Inflammation Research. Volume 14. 1207–1216. 11 indexed citations
9.
Chang, De, Lokesh Sharma, & Charles S. Dela Cruz. (2020). Harnessing Murine Microbiome Models to Study Human Lung Microbiome. CHEST Journal. 157(4). 776–778. 5 indexed citations
10.
Sharma, Lokesh, De Chang, & Charles S. Dela Cruz. (2020). Does inflammation help during COVID-19?. ERJ Open Research. 6(4). 557–2020. 4 indexed citations
11.
Young, Grant M., Xiaohua Peng, André Rebaza, et al.. (2020). Rapid decline of seasonal influenza during the outbreak of COVID-19. ERJ Open Research. 6(3). 296–2020. 12 indexed citations
12.
Chang, De, Peng Zhao, Dawei Zhang, et al.. (2020). Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2585–2591.e1. 33 indexed citations
13.
Chang, De, Lokesh Sharma, & Charles S. Dela Cruz. (2020). Chitotriosidase: a marker and modulator of lung disease. European Respiratory Review. 29(156). 190143–190143. 22 indexed citations
14.
Zhang, Yajuan, De Chang, & Jianpeng Zhang. (2017). Research Advances in Resistance to Platinum-based Chemotherapy in Lung Cancer.. PubMed. 39(1). 150–155. 8 indexed citations
15.
Chang, De, et al.. (2017). Genetic polymorphism and chronic obstructive pulmonary disease. International Journal of COPD. Volume 12. 1385–1393. 42 indexed citations
16.
Guo, Yinghua, Jia Li, Jinwen Liu, et al.. (2015). Effects of Space Environment on Genome, Transcriptome, and Proteome of Klebsiella pneumoniae. Archives of Medical Research. 46(8). 609–618. 11 indexed citations
17.
Wang, Junfeng, Changting Liu, Jinyi Liu, et al.. (2013). Space mutagenesis of genetically engineered bacteria expressing recombinant human interferon α1b and screening of higher yielding strains. World Journal of Microbiology and Biotechnology. 30(3). 943–949. 13 indexed citations
18.
You, Lei, De Chang, Hong‐Zhen Du, & Yupei Zhao. (2011). Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochemical and Biophysical Research Communications. 407(1). 1–6. 107 indexed citations
19.
Chang, De. (2009). The effect of Ejiao on the multiplicative and differentiative function of osteoblast of wistar rats cultured in vitro. Zhongguo laonianxue zazhi. 2 indexed citations
20.
Chang, J.K., et al.. (1986). Atrial natriuretic polypeptide-like material in rat lung. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026